(E)-3-(1,4-Dioxaspiro[4.5]dec-7-en-7-yl)acrylic acid

Catalog No. :
ACRPTZ049
CAS No. :
226916-19-4
Molecular Formula :
C11H14O4
Molecular Weight :
210.23

IUPAC Name:(E)-3-(1,4-dioxaspiro[4.5]dec-7-en-7-yl)acrylic acid

(E)-3-(1,4-Dioxaspiro[4.5]dec-7-en-7-yl)acrylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg97%$121.00Login to see priceInquiryInquiry
10mg97%$148.00Login to see priceInquiryInquiry
250mg97%$548.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-3-(1,4-Dioxaspiro[4.5]dec-7-en-7-yl)acrylic acid
IUPAC Name(E)-3-(1,4-dioxaspiro[4.5]dec-7-en-7-yl)acrylic acid
MDL No.MFCD13152280
Molecular FormulaC11H14O4
Molecular Weight210.23
SMILESOC(=O)\C=C\C1=CCCC2(C1)OCCO2
InChI KeyFWFDDYZZFODCDR-ONEGZZNKSA-N
Synonym(E)-3-(1,4-DIOXASPIRO[4.5]DEC-7-EN-7-YL)ACRYLIC ACID;3-(1,4-DIOXASPIRO[4.5]DEC-7-EN-7-YL)ACRYLIC ACID;(2E)-3-(1,4-Dioxaspiro[4.5]dec-7-en-7-yl)-2-propenoic acid;-3-(1,4-Dioxaspiro[4.5]dec-7-en-7-yl);2-Propenoicacid,3-(1,4-dioxaspiro[4.5]dec-7-en-7-yl)-,(2E)-;3-(1,4-dioxaspiro[4.5]dec-7-en-7-yl)prop-2-enoic acid;(2E)-3-{1,4-Dioxaspiro[4.5]dec-7-en-7-yl}prop-2-enoic acid;RSYY(Avanafil)-7
CAS No.226916-19-4
PubChem CID16100346

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACRPTZ049 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRPTZ049 route product structure diagram
    ACRPTZ049226916-19-4
Inquiry

2. ACRPTZ049 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRPTZ049 route product structure diagram
    ACRPTZ049226916-19-4
Inquiry

Comments (0)